Cargando…

Tedizolid clearance by in vitro continuous renal replacement therapy model

Detalles Bibliográficos
Autores principales:	Lewis, SJ, Switaj, L, Mueller, BA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471418/ http://dx.doi.org/10.1186/cc14193

Ejemplares similares

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Use of 2-hourly creatinine clearance to inform cessation of renal replacement therapy
por: Solymos, O, et al.
Publicado: (2011)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Stability of crushed tedizolid phosphate tablets for nasogastric tube administration
por: Kennedy, G, et al.
Publicado: (2015)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status
por: Morgera, S, et al.
Publicado: (2004)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
por: Andrews, Lauren, et al.
Publicado: (2021)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
por: Turani, F, et al.
Publicado: (2013)

Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model
por: Yoshikawa, Satoshi, et al.
Publicado: (2023)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy
por: Maldonado Toral, C, et al.
Publicado: (2015)

Systemic citrate load during continuous renal replacement therapy is not negligible and can be predicted using indirect methods
por: Zakharchenko, M, et al.
Publicado: (2011)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results
por: Jang, Soo M., et al.
Publicado: (2023)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Utilization of slow low-efficiency dialysis may help to optimize the need for continuous renal replacement therapy in Indian ICUs
por: Majumdar, A, et al.
Publicado: (2009)

High fluid volume removal with continuous renal replacement therapy as a therapeutic option for early posttraumatic acute respiratory distress syndrome
por: Sorrentino, L, et al.
Publicado: (2008)

A comparison between 2 dilute citrate solutions (15mmol/l vs 18 mmol/l) in continuous renal replacement therapy: the base excess and renal replacement solution (BEARRS) study
por: Anstey, CM, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_45i8e2iu4u3ip774gnao4h0tca